Dementia: An Overview

Authors

  • Nitin Bansal Department of Pharmacology, ASBASJSM College of Pharmacy, BELA (Ropar) Punjab-140111, India
  • Milind Parle Department of Pharmaceutical Sciences, Guru Jambhwshawar University of Science & Technology, Hisar, Haryana-125001, India

DOI:

https://doi.org/10.15415/jptrm.2014.21003

Keywords:

Amnesia, Alzheimer’s disease, Cognition, Dementia, Memory

Abstract

Dementia is a neurodegenerative disorder characterized by progressive and continuous loss of cognitive functions. The neuropsychiatric symptoms include apathy; agitation and depression. As the disorder progresses, the patient gradually becomes dependent on others to perform routine daily activities. Various underlying diseases or disorders are the root cause of the syndrome of dementia. Each of these disorder or disease is characterized by a specific signs and symptoms in combination with a presumed underlying neuropathology. Alzheimer’s disease is the most prevalent cause of dementia. The second most prevalent cause is vascular dementia. In this review, the clinical types, pathophysiology and pharmacotherapy is summarized.

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

References

Anand, A., Saraf, M. K., Prabhakar, S. (2007). Sustained inhibition of brotizolam induced anterograde amnesia by norharmane and retrograde amnesia by l-glutamic acid in

mice. Behavioural Brain Research, 182, 12-20. https://doi.org/10.1016/j.bbr.2007.04.022

Bassil, N., Morley, J.E. (2010). Endocrine aspects of healthy brain aging. Clinics in Geriatric Medicine, 26, 57-74. https://doi.org/10.1016/j.cger.2009.12.004

Budson, A. E., Price, B. H. (2005). Memory Dysfunction. New England Journal of Medicine, 352, 692-699. https://doi.org/10.1056/NEJMra041071

Caccamo, A., Fisher, A., LaFerla, F. M. (2009). M1 agonists as a potential disease-modifying therapy for Alzheimer’s disease. Current Alzheimer Research, 6, 112-117. https://doi.org/10.2174/156720509787602915

Carrera, E., Michel, P., Bogousslavsky, J. (2004). Anteromedian, central, and posterolateral infarcts of the thalamus: three variant types. Stroke, 35, 2826-2831. https://doi.org/10.1161/01.STR.0000147039.49252.2f

Chun, M. M. (2005). Drug-induced amnesia impairs implicit relational memory. Trends in Cognitive Sciences, 9, 355-357. https://doi.org/10.1016/j.tics.2005.06.015

Cipolotti, L., Shallice, T., Chan, D., Fox, N., Scahill, R., Harrison, G., Stevens, J., Rudge, P. (2001). Long-term retrograde amnesia the crucial role of the hippocampus. Neuropsychologia, 39, 151-172. https://doi.org/10.1016/S0028-3932(00)00103-2

Craft, S. (2009). The role of metabolic disorders in Alzheimer disease and vascular dementia: two roads converged. Archives of Neurology, 66, 300-305. https://doi.org/10.1001/archneurol.2009.27

Cummings, J. L. (2004). Alzheimer’s disease. New England Journal of Medicine, 351, 56 67. https://doi.org/10.1056/NEJMra040223

Cyngiser, T. A. (2008). Creutzfeldt-Jakob disease: a disease overview. American Journal of Electroneurodiagnostic Technology, 48, 199-208. PubMed ID-18998478

Deadwyler, S. A., Hampson, K. E. (1999). Anatomical model of hippocampal encoding of spatialinformation. Hippocampus, 9, 397-421.

DeKosky, S. T., Ikonomovic, M. D., Gandy, S. (2010). Traumatic brain injury--football, warfare, and long-term effects. New England Journal of Medicine, 363, 1293-1296. https://doi.org/10.1056/NEJMp1007051

Di Gennaro, G., Grammaldo, L. G., Quarato. P. P., Esposito, V., Mascia, A., Sparano, A., Meldolesi, G. N., Picardi, A. (2006). Severe amnesia following bilateral medial temporal lobe damage occurring on two distinct occasions. Journal of Neurological Sciences, 27, 129-133. https://doi.org/10.1007/s10072-006-0614-y

Dupiereux, I., Zorzi, W., Quadrio, I., Perret-Liaudet, A., Kovacs, G. G., Heinen, E., Elmoualij, B., Creutzfeldt-jakob. (2009). Parkinson, lewy body dementia and Alzheimer

diseases: from diagnosis to therapy Central Nervous System Agents in Medicinal Chemistry, 9, 2-11. https://doi.org/10.2174/187152409787601950

Ellis, K. A., Nathan, P. J. (2001). Pharmacology of human working memory. The International Journal of Neuropsychophrmacology, 4, 299-313. https://doi.org/10.1017/S1461145701002541

Esbenshade, T. A., Browman, K. E., Bitner, R. S., Strakhova, M., Cowart, M. D., Brioni, J. D. (2008). The histamine H3 receptor: an attractive target for the treatment of cognitive disorders. British Journal of Pharmacology, 154, 1166-81. https://doi.org/10.1038/bjp.2008.147

Fama, R., Marsh, L., Sullivan, E. V. (2004). Dissociation of remote and anterograde memory impairment and neural correlates in alcoholic Korsakoff syndrome. Journal of the International Neuropsychological Society, 10, 427-441. https://doi.org/10.1017/S135561770410310X

Farlow, M. R. (2009). Treatment of mild cognitive impairment (MCI). Current Alzheimer Research, 6, 362-367. https://doi.org/10.2174/156720509788929282

Fratiglioni, L., Winblad, B., Strauss, E. V. (2007). Prevention of Alzheimer’s disease and dementia. Major findings from the Kungsholmen Project. Physiology & Behaviour, 92, 98–104. https://doi.org/10.1016/j.physbeh.2007.05.059

Gilbert, M. E. (2000). In-vitro system as stimulation of in-vitro conditions: The study of cognition and synaptic plasticity in neurotoxicology. Annals of the New York Academy of Sciences, 919, 119-132. https://doi.org/10.1111/j.1749-6632.2000.tb06874.x

Herta, K. D., Sturzenegger, M., Berkhoff, M. (2005). Human immunodeficiency virus associated tuberculous meningoencephalitis causing abnormal behaviour in a prisoner. Der Nervenarzt, 76, 68-71. https://doi.org/10.1007/s00115-004-1702-y

Hillbom, M., Marttila, M. (2010). Encephalopathies due to vitamin deficiency. Duodecim, 126, 2132- 2138. PMID:21072960

Hindle, J. V. (2010). Ageing, neurodegeneration and Parkinson’s disease Age and Ageing, 39, 156-161. https://doi.org/10.1093/ageing/afp223

Hulse, G. K., Lautenschllger, N. T., Tait, R. J., Almeida, O. P. (2005). Dementia associated with alcohol and other drug use. International Psychogeriatrics, 17, S109-S127. https://doi.org/10.1017/S1041610205001985

Husband, A., Worsley, A. (2006). Different types of dementia. The Pharmaceutical Journal, 277, 579-582.

Kamphuis, P. J., Wurtman, R. J. (2009). Nutrition and Alzheimer’s disease: Preclinical concepts. European Journal of Neurology, 16, 12-18. https://doi.org/10.1111/j.14681331.2009.02737.x

Kazui, H. (2008). Cognitive impairment in patients with idiopathic normal pressure hydrocephalus. Brain and Nerve, 60, 225-231.

Korczyn, A. D., Halperin, I. (2009). Depression and dementia. Journal of Neurological Sciences, 283, 139-142. https://doi.org/10.1016/j.jns.2009.02.346

Krobitsch, S., Kazantsev, A. G. (2011). Huntington’s disease: From molecular basis to therapeutic advances. International Journal of Biochemestry & Cell Biology, 43, 20-24. https://doi.org/10.1016/j.biocel.2010.10.014

Kulisevsky. J., Pagonabarraga. J. (2009). Cognitive impairment in Parkinson’s disease: tools for diagnosis and assessment. Movement Disorders, 24, 1103-1110. https://doi.org/10.1002/mds.22506

Kupers, R. C., Fortin. A., Astrup, J., Gjedde, A., Ptito, M. (2004). Recovery of anterograde amnesia in a case of craniopharyngioma. Archives of Neurology, 61, 1948-1952. https://doi.org/10.1001/archneur.61.12.1948

Lillo, P., Hodges, J. R. (2009). Frontotemporal dementia and motor neuron disease: Overlappingclinicpathological disorders. Journal of Clinical Neuroscience, 16, 1131-1135. https://doi.org/10.1016/j.jocn.2009.03.005

Lindebooma, J., Weinstein, H. (2004). Neuropsychology of cognitive ageing, minimal cognitive impairment, Alzheimer’s disease, and vascular cognitive impairment. European Journal of Pharmacology, 490, 83-86. https://doi.org/10.1016/j.ejphar.2004.02.046

Liu, L., Groen, T. V., Kadish, I., Tollefsbo, T. O. (2009). DNA methylation impacts on learning and memory in aging. Neurobiology of Aging, 30, 549-60. https://doi.org/10.1016/j.neurobiolaging.2007.07.020

Lobo, A., Saz, P. (2005). Dementia. In: Textbook of psychosomatic medicine. Ed. Levenson, J. L. American Psychiatric Publishing Inc. pp. 131-169.

McIntosh, C., Chick, J. (2004). Alcohol and the nervous system. Journal of Neurology Neurosurgery & Psychiatry, 75, 16-21. https://doi.org/10.1136/jnnp.2004.045708

Nader, K., Scafe, G. E., LeDoux, J. E. (2000). The labile nature of consolidation theory. Nature Reviews Neuroscience, 1, 216-219. https://doi.org/10.1038/35044580

Nagano, I., Abe, K. (2004). Neurosyphilis. Nihon Rinsho, 62, 231-234.

Nalecz, K. A., Miecz, D., Berezowski, V., Cecchelli, R. (2004). Carnitine: transport and physiological functions in the brain. Molecular Aspects of Medicine, 25, 551-567. https://doi.org/10.1016/j.mam.2004.06.001

Neary, D., Snowden, J., Mann, D. (2005). Frontotemporal dementia. The Lancet Neurology, 4, 771-780. https://doi.org/10.1016/S1474-4422(05)70223-4

Okano, H., Hirano, T., Balaban, E. (2000). Learning and memory. Proceedings of the National Academy of Sciences, 97, 12403-12404. https://doi.org/10.1073/pnas.210381897

Olin, J., Schneider, L., Novit, A., Luczak, S. (2001). Hydergine for dementia Cochrane Database of Systemic Reviews, 2, CD000359. https://doi.org/10.1002/14651858.CD000359

Osimani, A., Berger, A., Friedman, J., Porat-Katz, B. S., Abarbanel, J. M. (2005). Neuropsychology of vitamin B12 deficiency in elderly dementia patients and control subjects. Journal of Geriatric Psychiatry and Neurology, 18, 33-38.

Parigi, A. D., Panza, F., Capurso, C., Solfrizzi, V. (2006). Nutritional factors, cognitive decline and dementia. Brain Research Bulletin, 69, 1-19. https://doi.org/10.1016/j.brainresbull.2005.09.020

Park, K. W., Seo, J. H., Yoon, G. U. (2007). Selective anterograde amnesia with thalamus andhippocampal lesions in neuro-Behcet’s disease. Clinical Neurology and

Neurosurgery, 109, 470-473. https://doi.org/10.1016/j.clineuro.2007.02.016

Parle, M., Singh, N., Vasudevan, M. (2006). Regular rehearsal helps in consolidation of Long term Memory. Journal of Sports Science and Medicine, 5, 80-88.

Phaf, H. R., Geurts, H., Eling, P. A. (2000). Word frequency and word stem completion in Korsakoff patients. Journal of Clinical and Experimental Neuropsychology, 22, 817-

https://doi.org/10.1076/jcen.22.6.817.956

Pike, C. J., Carroll, J. C., Rosario, E. R., Barron, A. M.(2009). Protective action of sex steroidhormones in alzheimer’s disease. Frontiers in Neuroendocrinology, 30, 239-258. https://doi.org/10.1016/j.yfrne.2009.04.015

Poreh, A., Winocur, G., Moscovitch, M., Backon, M., Goshen, E., Ram, Z., Feldman, Z.(2006). Anterograde and retrograde amnesia in a person with bilateral fornix lesions following removal of a colloid cyst. Neuropsychologia, 44, 2241-2248. https://doi.org/10.1016/j.neuropsychologia.2006.05.020

Ramirez-Amaya, V., Escoban, M. L., Chao, V., Bermudez-Rattoni, F. (1999). Synaptogenesis of mossy fibers induced by spatial water maze over training. Hippocampus, 9, 631-636.

Ratnavalli, E., Brayne, C., Dawson, K., Hodges, J. R. (2002). The prevalence of frontotemporal dementia. Neurology, 58, 1615-1621.

Robbins, T. W., Murphy, E. R. (2006). Behavioural pharmacology: 40+ years of progress, with a focus on glutamate receptors and cognition. Trends Pharmacological Sciences, 27, 141-148. https://doi.org/10.1016/j.tips.2006.01.009

Roman, G. C. (2002). Vascular dementia may be the most common form of dementia in the elderly. Journal of Neurological Sciences, 203–204, 7-10. https://doi.org/10.1016/S0022-510X(02)00252-6

Román, G. C. (2005). Vascular dementia prevention: a risk factor analysis. Cerebrovascular Diseases, 20, 91-100. https://doi.org/10.1159/000089361

Roze, E., Bonnet, C., Betuing, S., Caboche, J. (2010). Huntington’s disease Advences in experimental medicine and biology, 685, 45-63. https://doi.org/10.1007/978-1-4419-

-9_5

Scarpini, E., Scheltens, P., Feldman, H. (2003). Treatment of Alzheimer’s disease: current status and new perspectives. The Lancet Neurology, 2, 539-547. https://doi.org/10.1016/S1474-4422(03)00502-7

Schreurs, B. G. (2010). The effect of cholesterol on learning and memory. Neuroscience & Biobehavioral Reviews, 34, 1366-1379. https://doi.org/10.1016/j.neubiorev.2010.04.010

Schweickert, R. A. (1993). Multinomial processing tree model for degradation and redintegration in immediate recall. Memory & Cognition, 21, 168-175. https://doi.org/10.3758/BF03202729

Shah, R. S., Lee, H. G., Xiongwei, Z., Perry, G., Smith, M. A., Castellani, R. J. (2008). Current approaches in the treatment of Alzheimer’s disease. Biomedicine &

Pharmacotherapy, 62, 199-207. https://doi.org/10.1016/j.biopha.2008.02.005

Shaprine, M. L., Eichenbaum, H. (2000). Hippocampus is a memory map: synaptic plasticity andmemory encoding by hippocampus neuron. Hippocampus, 9, 365-384. https://doi.org/10.1002/(SICI)1098-1063(1999)9:4<365::AID-HIPO4>3.0.CO;2-T

Sharma, D. Bhattacharya, J. (2009). Cellular & molecular basis of HIV-associated neuropathogenesis. Indian Journal of Medical Research, 129, 637-651.

Shimizu, N. (2004). Wilson disease. Nihon Rinsho, 62, 399-403.

Silvestrelli, G., Lanari, A., Parnetti, L., Tomassoni, D., Amenta, F. (2006). Treatment of Alzheimer’s disease: From pharmacology to a better understanding of disease pathophysiology. Mechanisms of Ageing and Development, 127, 148–157.

Sjögren, M., Andersen, C. (2006). Frontotemporal dementia-a brief review. Mechanisms of Ageing and development, 127, 180-187.

Solntseva, E. I., Bukanova, Iu. V., Skrebitskii, V. G. (2003). Memory and potassium channels. Usp Fiziol Nauk 34, 16-25.

Staropoli, J. F. (2008). Tumorigenesis and neurodegeneration: two sides of the same coin? BioEssays, 30, 719-727. https://doi.org/10.1002/bies.20784

Stewart, W. F., Kawas, C., Corrada, M., Metter, E. J. (1997). Risk of Alzheimer’s disease and duration of NSAID use. Neurology, 48, 626-632. https://doi.org/10.1212/WNL.48.3.626

Summers, M. J. (2002). Neuropsychological consequences of right thalamic haemorrhage: case study and review. Brain and Cognition, 50, 129-138. https://doi.org/10.1016/S0278-2626(02)00017-9

Tampi, R. R., Williamson, D., Muralee, S., Mittal, V., McEnerney, N., Thomas, J., Cash, M. (2011). Behavioral and psychological symptoms of dementia: Part I- epidemiology,

neurobiology, heritability and evaluation. Clinical Geriatrics, 19, 1-6.

Thomas, S. J., Grossberg, G. T. (2009). Memantine: a review of studies into its safety and efficacy in treating Alzheimer’s disease and other dementias.Clinical Interventions in Aging, 4, 367-377. https://doi.org/10.2147/CIA.S6666

Tomassoni, D., Lanari, A., Silvestrelli, G., Traini, E., Amenta, F. (2008). Nimodipine and its use in cerebrovascular disease: evidence from recent preclinical and controlled clinical studies. Clinical and Experimental Hypertension, 30, 744-766. https://doi.org/10.1080/10641960802580232

Trinh, N. H., Hoblyn, J., Mohanty, S., Yaffe, K. (2003). Efficacy of cholinesterase inhibitors in the treatment of neuropsychiatric symptoms and functional impairment in Alzheimer disease: ameta-analysis. Journal of the American Medical Association, 280, 210-216. https://doi.org/10.1136/ebmh.6.3.94

Tuszynski, M. H. (2007). Nerve growth factor gene therapy in Alzheimer disease. Alzheimer Disease and Associated Disorders, 21, 179-189. https://doi.org/10.1097/WAD.0b013e318068d6d2

Vik, P.W., Cellucci, T., Jarchow, A., Hedt, J. (2004). Cognitive impairment in substance abuse. Psychiatric Clinicis of North America, 27, 97-109. https://doi.org/10.1016/S0193-953X(03)00110-2

Winnicka, K., Tomasiak, M., Bielawska, A. (2005). Piracetam- an old drug with novel properties? Acta Poloniae Pharmceutica, 62, 405-409.

Yaffe, K., Kanaya, A., Lindquist, K. et al. (2004). The metabolic syndrome, inflammation and risk of cognitive decline. Journal of the American Medical Association, 242, 2237-2242. https://doi.org/10.1001/jama.292.18.2237

Zandi, P.P., Anthony, J. C., Khachaturian, A. S., Stone, S. V., Gustafson, D., Tschanz, J. T., Norton, M. C., Welsh-Bohmer, K. A., Breitner, J. C. (2004). Cache County Study Group. Reduced risk of Alzheimer disease in users of antioxidant vitamin supplements: the Cache County Study. Archives of Neurology, 61, 82-88.

Downloads

Published

2014-05-07

How to Cite

Nitin Bansal, & Milind Parle. (2014). Dementia: An Overview. Journal of Pharmaceutical Technology, Research and Management, 2(1), 29–45. https://doi.org/10.15415/jptrm.2014.21003

Issue

Section

Articles